Oronza A Botrugno

6PUBLICATIONS
49CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)Epigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 04, 2026
The histone methyltransferase NSD3 oncogene triggers ribosomal DNA transcription, interfering with FOSL2 in cancer.

|Jan 08, 2026
TIGIT disruption rescues the antitumor activity of low avidity TCR-engineered T cells by increasing TCR signal strength.

Martina Spiga, Alessia Potenza, Zulma Magnani

|Feb 03, 2025
Early tolerance and late persistence as alternative drug responses in cancer.

Simona Punzi, Davide Cittaro, Guido Gatti

|May 02, 2024
Scalable integration of multiomic single-cell data using generative adversarial networks.

Valentina Giansanti, Francesca Giannese, Oronza A Botrugno

|Jan 11, 2022
Genomic Instability and Replicative Stress in Multiple Myeloma: The Final Curtain?

Oronza A Botrugno, Giovanni Tonon

|Oct 12, 2021
Chromatin Velocity reveals epigenetic dynamics by single-cell profiling of heterochromatin and euchromatin.

Martina Tedesco, Francesca Giannese, Dejan Lazarević

Pageof 1

Frequent Collaborators

6 joint publications

Giovanni Tonon

4 joint publications

Davide Cittaro

3 joint publications

Valentina Giansanti

2 joint publications

Gemma Crupi